ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
profitability factor · long-only model fund

Foundry Cash Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FCASHYPOTHETICAL MODEL
Since ’99
−49%
Expense Ratio
0.29%
placeholder
Holdings
329
cap-weighted
Inception
Nov 2019
placeholder
Full Sharpe
0.02
Ann. Return (LS)
0.6%
Ann. Volatility
24.2%
Max Drawdown
-80.4%
Test Sharpe ’19–26
-0.17
Test FF5 α (ann.)
-0.8%
vs Fama-French 5
Test FF5 α t-stat
-0.14
not significant
Monthly turnover
12%
of the long leg, per rebalance
Cumulative return (LS)
-49%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.29
what this fund holds
Long leg ann. return
8.0%
buyable, long-only
Long-short Sharpe
0.02
requires shorting
Bottom bucket ann. return
7.4%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

329 of 329 · 100.0% of book
TickerCompanySectorMarket capWeight
1CRWD
CROWDSTRIKE HOLDINGS INCTechnology$206.79B
9.62%
2APP
APPLOVIN CORPTechnology$142.62B
6.63%
3BKNG
BOOKING HOLDINGS INCIndustrials$140.78B
6.55%
4BNY
BANK OF NEW YORK MELLON CORPFinancial Services$107.85B
5.02%
5HOOD
ROBINHOOD MARKETS INCFinancial Services$90.01B
4.19%
6BE
BLOOM ENERGY CORPIndustrials$61.14B
2.84%
7LITE
LUMENTUM HOLDINGS INCTechnology$57.01B
2.65%
8STT
STATE STREET CORPFinancial Services$50.51B
2.35%
9LYV
LIVE NATION ENTERTAINMENT INCCommunication Services$42.45B
1.97%
10COIN
COINBASE GLOBAL INCFinancial Services$41.40B
1.93%
11CBRS
CEREBRAS SYSTEMS INCTechnology$39.16B
1.82%
12RKLB
ROCKET LAB CORPIndustrials$39.14B
1.82%
13NTRA
NATERA INCHealthcare$38.87B
1.81%
14CRDO
CREDO TECHNOLOGY GROUP HOLDING LTDTechnology$37.80B
1.76%
15ALNY
ALNYLAM PHARMACEUTICALS INCHealthcare$35.71B
1.66%
16RDDT
REDDIT INCCommunication Services$34.88B
1.62%
17ONC
BEONE MEDICINES LTDHealthcare$34.68B
1.61%
18CPNG
COUPANG INCConsumer Cyclical$29.83B
1.39%
19CPRT
COPART INCIndustrials$25.56B
1.19%
20VRSN
VERISIGN INCTechnology$25.27B
1.18%
21SYM
SYMBOTIC INCIndustrials$24.86B
1.16%
22CPAY
CORPAY INCTechnology$23.91B
1.11%
23INCY
INCYTE CORPHealthcare$23.42B
1.09%
24ASTS
AST SPACEMOBILE INCTechnology$22.43B
1.04%
25ROKU
ROKU INCCommunication Services$21.32B
0.99%
26GH
GUARDANT HEALTH INCHealthcare$20.67B
0.96%
27TOST
TOAST INCTechnology$17.45B
0.81%
28BBIO
BRIDGEBIO PHARMA INCHealthcare$15.94B
0.74%
29CRCL
CIRCLE INTERNET GROUP INCFinancial Services$15.03B
0.70%
30DECK
DECKERS OUTDOOR CORPConsumer Cyclical$14.79B
0.69%
31LOGI
LOGITECH INTERNATIONAL SATechnology$14.76B
0.69%
32SITM
SITIME CORPTechnology$14.65B
0.68%
33QNT
QUANTINUUM INCTechnology$14.54B
0.68%
34MLI
MUELLER INDUSTRIES INCIndustrials$13.08B
0.61%
35U
UNITY SOFTWARE INCTechnology$12.66B
0.59%
36AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.55%
37W
WAYFAIR INCConsumer Cyclical$11.79B
0.55%
38MOH
MOLINA HEALTHCARE INCHealthcare$11.74B
0.55%
39BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.54%
40VICR
VICOR CORPTechnology$10.83B
0.50%
41KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.49%
42APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.47%
43GME
GAMESTOP CORPConsumer Cyclical$9.82B
0.46%
44WULF
TERAWULF INCFinancial Services$9.00B
0.42%
45OSCR
OSCAR HEALTH INCHealthcare$8.77B
0.41%
46PRAX
PRAXIS PRECISION MEDICINES INCHealthcare$8.77B
0.41%
47KTOS
KRATOS DEFENSE & SECURITY SOLUTIONS INCIndustrials$8.63B
0.40%
48POWL
POWELL INDUSTRIES INCIndustrials$8.48B
0.39%
49IMVT
IMMUNOVANT INCHealthcare$8.27B
0.38%
50MP
MP MATERIALS CORPBasic Materials$8.05B
0.37%
51ETSY
ETSY INCConsumer Cyclical$7.98B
0.37%
52RSI
RUSH STREET INTERACTIVE INCConsumer Cyclical$7.56B
0.35%
53MIRM
MIRUM PHARMACEUTICALS INCHealthcare$7.25B
0.34%
54CIFR
CIPHER DIGITAL INCFinancial Services$7.18B
0.33%
55OKLO
OKLO INCUtilities$7.15B
0.33%
56DBX
DROPBOX INCTechnology$7.14B
0.33%
57JOBY
JOBY AVIATION INCIndustrials$7.11B
0.33%
58LQDA
LIQUIDIA CORPHealthcare$7.11B
0.33%
59FLR
FLUOR CORPIndustrials$6.86B
0.32%
60CORZ
CORE SCIENTIFIC INCTechnology$6.66B
0.31%
61NAVN
NAVAN INCTechnology$6.60B
0.31%
62XENE
XENON PHARMACEUTICALS INCHealthcare$6.60B
0.31%
63FIGR
FIGURE TECHNOLOGY SOLUTIONS INCFinancial Services$6.39B
0.30%
64SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.29%
65DUOL
DUOLINGO INCTechnology$6.24B
0.29%
66CVLT
COMMVAULT SYSTEMS INCTechnology$6.10B
0.28%
67BLLN
BILLIONTOONE INCHealthcare$5.99B
0.28%
68DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.27%
69VSEC
VSE CORPIndustrials$5.60B
0.26%
70TXG
10X GENOMICS INCHealthcare$5.55B
0.26%
71KVYO
KLAVIYO INCTechnology$5.29B
0.25%
72RELY
REMITLY GLOBAL INCTechnology$5.08B
0.24%
73ANDG
ANDERSEN GROUP INCConsumer Cyclical$5.02B
0.23%
74PTRN
PATTERN GROUP INCConsumer Cyclical$4.97B
0.23%
75DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.22%
76CAI
CARIS LIFE SCIENCES INCHealthcare$4.66B
0.22%
77MANE
VERADERMICS INCHealthcare$4.65B
0.22%
78LIF
LIFE360 INCTechnology$4.36B
0.20%
79CELC
CELCUITY INCHealthcare$4.31B
0.20%
80ALHC
ALIGNMENT HEALTHCARE INCHealthcare$4.26B
0.20%
81COCO
VITA COCO COMPANY INCConsumer Defensive$4.18B
0.19%
82TNGX
TANGO THERAPEUTICS INCHealthcare$4.13B
0.19%
83BETA
BETA TECHNOLOGIES INCIndustrials$4.10B
0.19%
84MIAX
MIAMI INTERNATIONAL HOLDINGS INCFinancial Services$4.02B
0.19%
85DYN
DYNE THERAPEUTICS INCHealthcare$3.92B
0.18%
86LASR
NLIGHT INCTechnology$3.91B
0.18%
87CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.18%
88PAY
PAYMENTUS HOLDINGS INCTechnology$3.75B
0.17%
89PBLS
PARABILIS MEDICINES INCHealthcare$3.51B
0.16%
90USAR
USA RARE EARTH INCBasic Materials$3.49B
0.16%
91WRBY
WARBY PARKER INCHealthcare$3.24B
0.15%
92ONDS
ONDAS INCTechnology$3.23B
0.15%
93CRVL
CORVEL CORPFinancial Services$3.13B
0.15%
94EEFT
EURONET WORLDWIDE INCTechnology$3.10B
0.14%
95LEU
CENTRUS ENERGY CORPBasic Materials$3.07B
0.14%
96WT
WISDOMTREE INCFinancial Services$3.07B
0.14%
97USLM
UNITED STATES LIME & MINERALS INCBasic Materials$3.01B
0.14%
98FRSH
FRESHWORKS INCTechnology$3.01B
0.14%
99XNDU
XANADU QUANTUM TECHNOLOGIES LTDTechnology$2.98B
0.14%
100FIZZ
NATIONAL BEVERAGE CORPConsumer Defensive$2.91B
0.14%
101TDC
TERADATA CORPTechnology$2.87B
0.13%
102AVPT
AVEPOINT INCTechnology$2.80B
0.13%
103TNET
TRINET GROUP INCIndustrials$2.74B
0.13%
104VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.13%
105SOUN
SOUNDHOUND AI INCTechnology$2.71B
0.13%
106NVTS
NAVITAS SEMICONDUCTOR CORPTechnology$2.68B
0.12%
107KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.12%
108TMDX
TRANSMEDICS GROUP INCHealthcare$2.56B
0.12%
109PTON
PELOTON INTERACTIVE INCConsumer Cyclical$2.55B
0.12%
110IMNM
IMMUNOME INCHealthcare$2.53B
0.12%
111RUM
RUMBLE INCTechnology$2.51B
0.12%
112BLBD
BLUE BIRD CORPConsumer Cyclical$2.48B
0.12%
113SLS
SELLAS LIFE SCIENCES GROUP INCHealthcare$2.45B
0.11%
114BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.11%
115SLDE
SLIDE INSURANCE HOLDINGS INCFinancial Services$2.35B
0.11%
116BHVN
BIOHAVEN LTDHealthcare$2.32B
0.11%
117NG
NOVAGOLD RESOURCES INCBasic Materials$2.27B
0.11%
118HCI
HCI GROUP INCFinancial Services$2.27B
0.11%
119PVLA
PALVELLA THERAPEUTICS INCHealthcare$2.26B
0.10%
120PPTA
PERPETUA RESOURCES CORPBasic Materials$2.11B
0.10%
121SIND
SYNTHETIC INDUSTRIES INCConsumer Cyclical$2.03B
0.09%
122INOD
INNODATA INCTechnology$1.99B
0.09%
123PLSE
PULSE BIOSCIENCES INCHealthcare$1.98B
0.09%
124AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.09%
125OCUL
OCULAR THERAPEUTIX INCHealthcare$1.96B
0.09%
126URGN
UROGEN PHARMA LTDHealthcare$1.96B
0.09%
127HRMY
HARMONY BIOSCIENCES HOLDINGS INCHealthcare$1.96B
0.09%
128DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.09%
129ZBIO
ZENAS BIOPHARMA INCHealthcare$1.86B
0.09%
130MQ
MARQETA INCTechnology$1.85B
0.09%
131BCAX
BICARA THERAPEUTICS INCHealthcare$1.82B
0.08%
132LIND
LINDBLAD EXPEDITIONS HOLDINGS INCIndustrials$1.81B
0.08%
133STOK
STOKE THERAPEUTICS INCHealthcare$1.81B
0.08%
134ALMR
ALAMAR BIOSCIENCES INCHealthcare$1.80B
0.08%
135RVLV
REVOLVE GROUP INCConsumer Cyclical$1.78B
0.08%
136IMCR
IMMUNOCORE HOLDINGS PLCHealthcare$1.78B
0.08%
137ZYME
ZYMEWORKS INCHealthcare$1.77B
0.08%
138HYMC
HYCROFT MINING HOLDING CORPBasic Materials$1.74B
0.08%
139BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.08%
140TSHA
TAYSHA GENE THERAPIES INCHealthcare$1.71B
0.08%
141TRIP
TRIPADVISOR INCIndustrials$1.70B
0.08%
142ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.08%
143LIME
NEUTRON HOLDINGS INCTechnology$1.68B
0.08%
144STDN
STANDARD NUCLEAR INCBasic Materials$1.67B
0.08%
145CMPS
COMPASS PATHWAYS PLCHealthcare$1.67B
0.08%
146INVA
INNOVIVA INCHealthcare$1.60B
0.07%
147IDT
IDT CORPCommunication Services$1.57B
0.07%
148MAZE
MAZE THERAPEUTICS INCHealthcare$1.56B
0.07%
149AMBQ
AMBIQ MICRO INCTechnology$1.55B
0.07%
150VOYG
VOYAGER TECHNOLOGIES INCIndustrials$1.53B
0.07%
151XZO
EXZEO GROUP INCFinancial Services$1.46B
0.07%
152VIA
VIA TRANSPORTATION INCTechnology$1.46B
0.07%
153TRS
TRIMAS CORPConsumer Cyclical$1.46B
0.07%
154MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.07%
155ARLO
ARLO TECHNOLOGIES INCBasic Materials$1.45B
0.07%
156WOLF
WOLFSPEED INCTechnology$1.44B
0.07%
157AMPX
AMPRIUS TECHNOLOGIES INCIndustrials$1.44B
0.07%
158TWFG
TWFG INCFinancial Services$1.43B
0.07%
159WBTN
WEBTOON ENTERTAINMENT INCTechnology$1.41B
0.07%
160OMDA
OMADA HEALTH INCHealthcare$1.41B
0.07%
161WINA
WINMARK CORPConsumer Cyclical$1.39B
0.06%
162REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.06%
163AKTS
AKTIS ONCOLOGY INCHealthcare$1.33B
0.06%
164LZ
LEGALZOOMCOM INCIndustrials$1.33B
0.06%
165PBT
PERMIAN BASIN ROYALTY TRUSTEnergy$1.32B
0.06%
166NSSC
NAPCO SECURITY TECHNOLOGIES INCIndustrials$1.29B
0.06%
167IE
IVANHOE ELECTRIC INCBasic Materials$1.29B
0.06%
168INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.06%
169TRAX
FIRST TRACKS BIOTHERAPEUTICS INCUnclassified$1.27B
0.06%
170AVLN
AVALYN PHARMA INCHealthcare$1.25B
0.06%
171FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.06%
172IRMD
IRADIMED CORPHealthcare$1.24B
0.06%
173LQDT
LIQUIDITY SERVICES INCConsumer Cyclical$1.23B
0.06%
174SDGR
SCHRODINGER INCHealthcare$1.14B
0.05%
175WVE
WAVE LIFE SCIENCES LTDHealthcare$1.12B
0.05%
176PRCT
PROCEPT BIOROBOTICS CORPHealthcare$1.09B
0.05%
177SHAZ
SHARONAI HOLDINGS INCTechnology$1.07B
0.05%
178GRPN
GROUPON INCCommunication Services$1.06B
0.05%
179BIOA
BIOAGE LABS INCHealthcare$1.01B
0.05%
180FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.05%
181BBSI
BARRETT BUSINESS SERVICES INCIndustrials$984M
0.05%
182VOR
VOR BIOPHARMA INCHealthcare$980M
0.05%
183ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.04%
184LWLG
LIGHTWAVE LOGIC INCBasic Materials$960M
0.04%
185ANNX
ANNEXON INCHealthcare$950M
0.04%
186ROOT
ROOT INCFinancial Services$944M
0.04%
187COUR
COURSERA INCConsumer Defensive$941M
0.04%
188RCAT
RED CAT HOLDINGS INCTechnology$938M
0.04%
189APEI
AMERICAN PUBLIC EDUCATION INCConsumer Defensive$930M
0.04%
190EVER
EVERQUOTE INCCommunication Services$925M
0.04%
191RDVT
RED VIOLET INCTechnology$920M
0.04%
192LBRX
LB PHARMACEUTICALS INCHealthcare$901M
0.04%
193TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.04%
194PHAT
PHATHOM PHARMACEUTICALS INCHealthcare$873M
0.04%
195REPL
REPLIMUNE GROUP INCHealthcare$859M
0.04%
196SLDB
SOLID BIOSCIENCES INCHealthcare$859M
0.04%
197NNE
NANO NUCLEAR ENERGY INCIndustrials$835M
0.04%
198CYRX
CRYOPORT INCIndustrials$832M
0.04%
199AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.04%
200UMAC
UNUSUAL MACHINES INCIndustrials$809M
0.04%
201OFRM
ONCE UPON A FARM PBCConsumer Defensive$761M
0.04%
202METC
RAMACO RESOURCES INCBasic Materials$760M
0.04%
203ZVRA
ZEVRA THERAPEUTICS INCHealthcare$755M
0.04%
204DSP
VIANT TECHNOLOGY INCTechnology$754M
0.04%
205CADL
CANDEL THERAPEUTICS INCHealthcare$746M
0.03%
206MNPR
MONOPAR THERAPEUTICSHealthcare$744M
0.03%
207IBTA
IBOTTA INCTechnology$734M
0.03%
208AURA
AURA BIOSCIENCES INCHealthcare$723M
0.03%
209PKE
PARK AEROSPACE CORPIndustrials$677M
0.03%
210SGP
SPYGLASS PHARMA INCHealthcare$661M
0.03%
211MNTN
MNTN INCTechnology$661M
0.03%
212LPTH
LIGHTPATH TECHNOLOGIES INCTechnology$657M
0.03%
213ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.03%
214FISN
DEEP FISSION INCIndustrials$643M
0.03%
215TECX
TECTONIC THERAPEUTIC INCHealthcare$615M
0.03%
216FAC
FACTORIAL ENERGY INCIndustrials$610M
0.03%
217NGNE
NEUROGENE INCHealthcare$590M
0.03%
218STTK
SHATTUCK LABS INCHealthcare$577M
0.03%
219IMMX
IMMIX BIOPHARMA INCHealthcare$558M
0.03%
220ELA
ENVELA CORPConsumer Cyclical$547M
0.03%
221ALOY
REALLOYS INCBasic Materials$544M
0.03%
222VSTM
VERASTEM INCHealthcare$530M
0.02%
223EROC
EAGLE ROCK ENERGY PARTNERS L PEnergy$520M
0.02%
224ZURA
ZURA BIO LTDHealthcare$518M
0.02%
225NVCT
NUVECTIS PHARMA INCHealthcare$508M
0.02%
226XOMA
XOMA ROYALTY CORPHealthcare$504M
0.02%
227GDYN
GRID DYNAMICS HOLDINGS INCTechnology$484M
0.02%
228SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.02%
229PAYS
PAYSIGN INCTechnology$478M
0.02%
230CWCO
CONSOLIDATED WATER CO LTDUtilities$467M
0.02%
231CLPT
CLEARPOINT NEURO INCHealthcare$454M
0.02%
232PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.02%
233DCTH
DELCATH SYSTEMS INCHealthcare$442M
0.02%
234BNTC
BENITEC BIOPHARMA INCHealthcare$439M
0.02%
235ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.02%
236TENX
TENAX THERAPEUTICS INCHealthcare$420M
0.02%
237SWMR
SWARMER INCTechnology$410M
0.02%
238CBIO
CRESCENT BIOPHARMA INCHealthcare$407M
0.02%
239MOBI
MOBIA MEDICAL INCHealthcare$404M
0.02%
240NATH
NATHANS FAMOUS INCConsumer Cyclical$393M
0.02%
241BBBY
BED BATH & BEYOND INCConsumer Cyclical$372M
0.02%
242GNE
GENIE ENERGY LTDUtilities$369M
0.02%
243FENC
FENNEC PHARMACEUTICALS INCHealthcare$365M
0.02%
244OSPRU
OSPREY ACQUISITION CORP IIIUnclassified$362M
0.02%
245NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.02%
246MTRX
MATRIX SERVICE COIndustrials$342M
0.02%
247MRAM
EVERSPIN TECHNOLOGIES INCTechnology$341M
0.02%
248CV
CAPSOVISION INCHealthcare$335M
0.02%
249RTAC
RENATUS TACTICAL ACQUISITION CORP IIndustrials$329M
0.02%
250MPTI
M-TRON INDUSTRIES INCTechnology$328M
0.02%
251BKKT
BAKKT INCTechnology$323M
0.02%
252MSB
MESABI TRUSTBasic Materials$320M
0.01%
253CARL
CARLSMED INCHealthcare$317M
0.01%
254OSS
ONE STOP SYSTEMS INCTechnology$313M
0.01%
255BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.01%
256FHTX
FOGHORN THERAPEUTICS INCHealthcare$305M
0.01%
257OFLX
OMEGA FLEX INCIndustrials$302M
0.01%
258KPET
KPET ULTRA PACELINE CORPIndustrials$289M
0.01%
259UCFI
CN HEALTHY FOOD TECH GROUP CORPConsumer Defensive$288M
0.01%
260MASS
908 DEVICES INCHealthcare$278M
0.01%
261TSSI
TSS INCTechnology$274M
0.01%
262SGHT
SIGHT SCIENCES INCHealthcare$274M
0.01%
263TTRX
TURN THERAPEUTICS INCHealthcare$272M
0.01%
264CEPO
CANTOR EQUITY PARTNERS I INCIndustrials$271M
0.01%
265ALMU
AELUMA INCTechnology$267M
0.01%
266CNXU
CONEXEU SCIENCES INCHealthcare$263M
0.01%
267LTBR
LIGHTBRIDGE CORPIndustrials$256M
0.01%
268QTTB
Q32 BIO INCHealthcare$255M
0.01%
269SRZN
SURROZEN INCHealthcare$255M
0.01%
270VNME
VENDOME ACQUISITION CORP IIndustrials$254M
0.01%
271RNAC
CARTESIAN THERAPEUTICS INCHealthcare$243M
0.01%
272SOCA
SOLARIUS CAPITAL ACQUISITION CORPIndustrials$241M
0.01%
273GLSI
GREENWICH LIFESCIENCES INCHealthcare$240M
0.01%
274USAU
US GOLD CORPBasic Materials$235M
0.01%
275UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.01%
276REA
RARE EARTHS AMERICAS INCBasic Materials$220M
0.01%
277ATOM
ATOMERA INCTechnology$218M
0.01%
278KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.01%
279KROS
KEROS THERAPEUTICS INCHealthcare$211M
0.01%
280GSIT
GSI TECHNOLOGY INCTechnology$208M
0.01%
281RNA
ATRIUM THERAPEUTICS INCHealthcare$208M
0.01%
282IMUX
IMMUNIC INCHealthcare$207M
0.01%
283DTIL
PRECISION BIOSCIENCES INCHealthcare$203M
0.01%
284AMWL
AMERICAN WELL CORPHealthcare$199M
0.01%
285TNXP
TONIX PHARMACEUTICALS HOLDING CORPHealthcare$198M
0.01%
286ACOG
ALPHA COGNITION INCHealthcare$185M
0.01%
287EGAN
EGAIN CORPTechnology$180M
0.01%
288INGN
INOGEN INCHealthcare$178M
0.01%
289KVHI
KVH INDUSTRIES INCTechnology$178M
0.01%
290KRRO
KORRO BIO INCHealthcare$177M
0.01%
291ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.01%
292NUCL
EAGLE NUCLEAR ENERGY CORPBasic Materials$166M
0.01%
293OWLT
OWLET INCHealthcare$162M
0.01%
294TRAK
REPOSITRAK INCTechnology$160M
0.01%
295UNCY
UNICYCIVE THERAPEUTICS INCHealthcare$144M
0.01%
296ACNT
ASCENT INDUSTRIES COBasic Materials$138M
0.01%
297OTAI
STARLINK AI ACQUISITION CORPIndustrials$137M
0.01%
298PMN
PROMIS NEUROSCIENCES INCHealthcare$136M
0.01%
299AXR
AMREP CORPReal Estate$136M
0.01%
300FIRY
FIRY INCTechnology$130M
0.01%
301VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.01%
302AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.01%
303JYNT
JOINT CORPHealthcare$127M
0.01%
304CUE
CUE BIOPHARMA INCHealthcare$126M
0.01%
305BUDA
BUDA JUICE INCUnclassified$121M
0.01%
306SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.01%
307AMCI
AMC ROBOTICS CORPTechnology$114M
0.01%
308CODA
CODA OCTOPUS GROUP INCIndustrials$113M
0.01%
309USGO
US GOLDMINING INCBasic Materials$109M
0.01%
310RACC
RESEARCH ALLIANCE CORP IIIIndustrials$101M
0.00%
311ROC
RANK ONE COMPUTING CORPTechnology$98M
0.00%
312VRCA
VERRICA PHARMACEUTICALS INCHealthcare$96M
0.00%
313RLYB
RALLYBIO CORPHealthcare$87M
0.00%
314SOTK
SONO TEK CORPTechnology$86M
0.00%
315NRXS
NEURAXIS INCHealthcare$84M
0.00%
316WATT
ENERGOUS CORPTechnology$83M
0.00%
317CSPI
CSP INCTechnology$82M
0.00%
318HNNA
HENNESSY ADVISORS INCFinancial Services$79M
0.00%
319ROLR
HIGH ROLLER TECHNOLOGIES INCConsumer Cyclical$76M
0.00%
320ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.00%
321LONA
LEONABIO INCHealthcare$68M
0.00%
322IMA
IMAGENEBIO INCHealthcare$61M
0.00%
323EDSA
EDESA BIOTECH INCHealthcare$59M
0.00%
324TACT
TRANSACT TECHNOLOGIES INCTechnology$54M
0.00%
325INKT
MINK THERAPEUTICS INCHealthcare$53M
0.00%
326XLO
XILIO THERAPEUTICS INCHealthcare$53M
0.00%
327MCRB
SERES THERAPEUTICS INCHealthcare$52M
0.00%
328EXOZ
EXOZYMES INCHealthcare$51M
0.00%
329ACFN
ACORN ENERGY INCTechnology$51M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $2.15T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

12 sectors
Technology
34.7%
Healthcare
19.9%
Industrials
17.0%
Financial Services
16.1%
Consumer Cyclical
5.0%
Communication Services
4.8%
Basic Materials
1.5%
Consumer Defensive
0.5%
Utilities
0.4%
Energy
0.1%
Unclassified
0.1%
Real Estate
0.0%

Portfolio Style

Size × value map of the long-leg book

329 classified
Value
Blend
Growth
Large
Mid
Small
3%3
23%22
53%37
2%22
4%38
6%52
<1%31
1%46
1%35

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 92% toward Large, 80% toward Growth. +8% unclassified (43 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt92% → Large
SmallLarge
Value ↔ growth tilt80% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 329 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
3
Failed
2
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    27.5%
    Margin
    -2.5%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 329 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
2.3 (95% CI 1.3-3.1)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
21.9%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
2.27x
over
parametric
1.81x
within
cornish fisher
2.11x
over

The estimators disagree about the verdict, not just the value — the choice of method decides the answer here. Historical VaR gives ratio 2.27 (fail) but Gaussian VaR gives 1.81 (pass). The pass/fail conclusion is an artefact of estimator choice, not a property of the strategy.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2012
Before publication (pre-2012)
0.06
Sharpe · 1.7% p.a.
January 1999December 2012 · 168 mo
Since publication
-0.02
Sharpe · -0.5% p.a.
January 2013July 2026 · 163 mo
Change in Sharpe−0.09the return reversed sign — the published edge now runs the other way

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
69%
18 of 26 3-year windows made money
Worst window
-1.32
Sharpe, January 2021 – December 2023
January 1999July 2026
Median Sharpe
0.27
Dispersion
0.60
Best window
1.31

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.-1.1%-12.5%
3 yearsp.a.12.8%-0.3%
5 yearsp.a.-7.5%-15.9%
10 yearsp.a.6.5%-2.7%
Since inceptionp.a.4.1%-2.4%
Calendar years
YearLong legLong-short
20267 mo3.6%-11.0%
202518.6%15.5%
202410.5%-5.6%
202329.5%24.4%
2022-50.5%-51.3%
2021-33.6%-50.4%
202072.7%76.0%
201937.8%9.7%
2018-2.7%3.6%
201733.2%26.7%
2016-0.9%-16.9%
2015-6.3%3.0%
20147.4%-3.6%
201340.7%11.8%
201217.4%7.5%
2011-1.6%-3.8%
201022.0%4.1%
200944.4%18.9%
2008-45.7%-13.5%
200722.1%16.1%
20069.1%-7.8%
200514.8%8.2%
20048.6%0.1%
200354.3%27.5%
2002-28.6%-13.8%
2001-37.0%-33.2%
2000-50.7%-58.0%
199994.2%89.8%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FCAS
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2019-11-10 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$2.15T

Methodology

The Foundry Cash Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Cash signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.